| scholarly article | Q13442814 |
| P50 | author | Thomas S K Gilbert | Q88512227 |
| P2093 | author name string | Gary L Johnson | |
| Eric Lazear | |||
| Nathaniel J Moorman | |||
| Lee M Graves | |||
| Michael P East | |||
| Kyle C Arend | |||
| Heather A Vincent | |||
| Laura E Herring | |||
| Erik M Lenarcic | |||
| Naim Rashid | |||
| Ian M McDonald | |||
| P2860 | cites work | Substrate specificity and activity regulation of protein kinase MELK | Q24338012 |
| Human Cytomegalovirus Strategies to Maintain and Promote mRNA Translation | Q26752742 | ||
| The DNA damage response induced by infection with human cytomegalovirus and other viruses | Q26825363 | ||
| The dynamic nature of the kinome | Q26852588 | ||
| OTSSP167 Abrogates Mitotic Checkpoint through Inhibiting Multiple Mitotic Kinases | Q27313731 | ||
| Acetyl-lysine Binding Site of Bromodomain-Containing Protein 4 (BRD4) Interacts with Diverse Kinase Inhibitors | Q27681896 | ||
| Spectrum and Degree of CDK Drug Interactions Predicts Clinical Performance | Q27725532 | ||
| TGFβ signalling in context | Q28275410 | ||
| Decoding human cytomegalovirus | Q28279933 | ||
| Proteomics analysis of protein kinases by target class-selective prefractionation and tandem mass spectrometry | Q28280900 | ||
| Dynamics of the cellular metabolome during human cytomegalovirus infection | Q28469080 | ||
| Cyclin-dependent kinase activity controls the onset of the HCMV lytic cycle | Q28475459 | ||
| Application of multiplexed kinase inhibitor beads to study kinome adaptations in drug-resistant leukemia | Q28534259 | ||
| A screen of approved drugs and molecular probes identifies therapeutics with anti-Ebola virus activity | Q30279239 | ||
| Human cytomegalovirus UL99-encoded pp28 is required for the cytoplasmic envelopment of tegument-associated capsids. | Q30333473 | ||
| Systems-level metabolic flux profiling identifies fatty acid synthesis as a target for antiviral therapy | Q33675261 | ||
| Quantitative temporal viromics: an approach to investigate host-pathogen interaction | Q33722378 | ||
| Maternal embryonic leucine zipper kinase: key kinase for stem cell phenotype in glioma and other cancers | Q33723151 | ||
| MELK is an oncogenic kinase essential for mitotic progression in basal-like breast cancer cells. | Q33762222 | ||
| Rapamycin-resistant mTORC1 kinase activity is required for herpesvirus replication | Q33826815 | ||
| Human cytomegalovirus up-regulates the phosphatidylinositol 3-kinase (PI3-K) pathway: inhibition of PI3-K activity inhibits viral replication and virus-induced signaling | Q33842473 | ||
| A targeted spatial-temporal proteomics approach implicates multiple cellular trafficking pathways in human cytomegalovirus virion maturation | Q33854974 | ||
| Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors | Q34005966 | ||
| Eph receptors and ephrins in cancer: bidirectional signalling and beyond | Q34021365 | ||
| HCMV targets the metabolic stress response through activation of AMPK whose activity is important for viral replication | Q34145695 | ||
| Management of cytomegalovirus infection and disease after solid-organ transplantation | Q34271684 | ||
| Statistical protein quantification and significance analysis in label-free LC-MS experiments with complex designs | Q34486911 | ||
| Development of an orally-administrative MELK-targeting inhibitor that suppresses the growth of various types of human cancer | Q34530885 | ||
| Identification of 53 compounds that block Ebola virus-like particle entry via a repurposing screen of approved drugs | Q35050840 | ||
| Quantitative proteomics of kinase inhibitor targets and mechanisms | Q35489462 | ||
| Inhibition of Lapatinib-Induced Kinome Reprogramming in ERBB2-Positive Breast Cancer by Targeting BET Family Bromodomains | Q35533503 | ||
| An unbiased proteomics approach to identify human cytomegalovirus RNA-associated proteins | Q35625050 | ||
| Repurposing Kinase Inhibitors as Antiviral Agents to Control Influenza A Virus Replication | Q35698322 | ||
| Effect of 9-(1,3-dihydroxy-2-propoxymethyl)guanine on human cytomegalovirus replication in vitro | Q35755008 | ||
| Human kinome profiling identifies a requirement for AMP-activated protein kinase during human cytomegalovirus infection | Q35778951 | ||
| Characterization of the human cytomegalovirus irs1 and trs1 genes: a second immediate-early transcription unit within irs1 whose product antagonizes transcriptional activation. | Q35877408 | ||
| Dynamic reprogramming of the kinome in response to targeted MEK inhibition in triple-negative breast cancer | Q35895370 | ||
| Sirolimus-based graft-versus-host disease prophylaxis protects against cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation: a cohort analysis | Q35900978 | ||
| Drug Repurposing Approach Identifies Inhibitors of the Prototypic Viral Transcription Factor IE2 that Block Human Cytomegalovirus Replication | Q35923815 | ||
| Mitotic MELK-eIF4B signaling controls protein synthesis and tumor cell survival | Q36104705 | ||
| Human cytomegalovirus IE1 and IE2 proteins block apoptosis | Q39872769 | ||
| Effective Antiviral Chemotherapy in Cytomegalovirus Infection of Mice | Q39996614 | ||
| Cyclin-dependent kinase activity is required for efficient expression and posttranslational modification of human cytomegalovirus proteins and for production of extracellular particles | Q40274359 | ||
| A High-Throughput Targeted Proteomic Approach for Comprehensive Profiling of Methylglyoxal-Induced Perturbations of the Human Kinome | Q41976211 | ||
| Resistance to BET Bromodomain Inhibitors Is Mediated by Kinome Reprogramming in Ovarian Cancer | Q42382162 | ||
| Cloning and sequencing of a highly productive, endotheliotropic virus strain derived from human cytomegalovirus TB40/E. | Q45397798 | ||
| Estimation of covariate effects in generalized linear mixed models with a misspecified distribution of random intercepts and slopes | Q46832816 | ||
| "Going KiNativ": probing the Native Kinome. | Q54579441 | ||
| The role of MKK1/2 kinase activity in human cytomegalovirus infection | Q73426889 | ||
| BET inhibitor OTX015 targets BRD2 and BRD4 and decreases c-MYC in acute leukemia cells | Q36232141 | ||
| Transcriptome analysis of NF-kappaB- and phosphatidylinositol 3-kinase-regulated genes in human cytomegalovirus-infected monocytes | Q36424532 | ||
| Human cytomegalovirus. IV. Specific inhibition of virus-induced DNA polymerase activity and viral DNA replication by phosphonoacetic acid | Q36569646 | ||
| The S phase of the cell cycle and its perturbation by human cytomegalovirus | Q36901744 | ||
| The eIF4AIII RNA helicase is a critical determinant of human cytomegalovirus replication | Q37003223 | ||
| Maternal embryonic leucine zipper kinase (MELK) reduces replication stress in glioblastoma cells | Q37099799 | ||
| Human cytomegalovirus modulation of signal transduction | Q37219989 | ||
| Subversion of cell cycle regulatory pathways | Q37219997 | ||
| Multiple Transcripts Encode Full-Length Human Cytomegalovirus IE1 and IE2 Proteins during Lytic Infection | Q37252997 | ||
| Large-scale proteomics analysis of the human kinome | Q37258113 | ||
| Human cytomegalovirus protein UL38 inhibits host cell stress responses by antagonizing the tuberous sclerosis protein complex | Q37380692 | ||
| Differential role for host translation factors in host and viral protein synthesis during human cytomegalovirus infection | Q37547266 | ||
| Molecular targets for antiviral therapy of cytomegalovirus infections | Q37573779 | ||
| TGF-β induces M2-like macrophage polarization via SNAIL-mediated suppression of a pro-inflammatory phenotype | Q37588446 | ||
| Identification of compounds with anti-human cytomegalovirus activity that inhibit production of IE2 proteins | Q37594022 | ||
| Human cytomegalovirus encodes a highly specific RANTES decoy receptor | Q37692751 | ||
| New developments in the management of cytomegalovirus infection after solid organ transplantation | Q37756120 | ||
| Drug interactions and toxicities associated with the antiviral management of cytomegalovirus infection | Q37780903 | ||
| Tinkering with translation: protein synthesis in virus-infected cells | Q38064834 | ||
| Assessing adaptation of the cancer kinome in response to targeted therapies | Q38238603 | ||
| The pathogenesis of human cytomegalovirus. | Q38247785 | ||
| Mechanisms of ephrin-Eph signalling in development, physiology and disease. | Q38704281 | ||
| Human Cytomegalovirus: Coordinating Cellular Stress, Signaling, and Metabolic Pathways | Q38766612 | ||
| Human Cytomegalovirus pTRS1 and pIRS1 Antagonize Protein Kinase R To Facilitate Virus Replication | Q38798976 | ||
| BET Bromodomain Inhibitors Enhance Efficacy and Disrupt Resistance to AR Antagonists in the Treatment of Prostate Cancer | Q38801131 | ||
| Evaluation of Kinase Activity Profiling Using Chemical Proteomics | Q38834756 | ||
| Inhibitors of cellular kinases with broad-spectrum antiviral activity for hemorrhagic fever viruses | Q38873537 | ||
| The BET Bromodomain Inhibitor OTX015 Affects Pathogenetic Pathways in Preclinical B-cell Tumor Models and Synergizes with Targeted Drugs. | Q38916281 | ||
| High-throughput screening of a GlaxoSmithKline protein kinase inhibitor set identifies an inhibitor of human cytomegalovirus replication that prevents CREB and histone H3 post-translational modification | Q39013996 | ||
| Innovation in the pharmaceutical industry: New estimates of R&D costs | Q39194484 | ||
| Probing the global kinome and phosphoproteome in Chlamydomonas reinhardtii via sequential enrichment and quantitative proteomics | Q39349119 | ||
| Human Cytomegalovirus Stimulates the Synthesis of Select Akt-Dependent Antiapoptotic Proteins during Viral Entry To Promote Survival of Infected Monocytes. | Q39601708 | ||
| Molecular pathways: adaptive kinome reprogramming in response to targeted inhibition of the BRAF-MEK-ERK pathway in cancer | Q39697330 | ||
| Human Cytomegalovirus Induces an Atypical Activation of Akt To Stimulate the Survival of Short-Lived Monocytes. | Q39792977 | ||
| P433 | issue | 4 suppl 1 | |
| P921 | main subject | Cytomegalovirus | Q6946 |
| kinome | Q3197188 | ||
| P304 | page(s) | S263-S276 | |
| P577 | publication date | 2017-02-25 | |
| P1433 | published in | Molecular & Cellular Proteomics | Q6895932 |
| P1476 | title | Kinome Profiling Identifies Druggable Targets for Novel Human Cytomegalovirus (HCMV) Antivirals | |
| P478 | volume | 16 |
| Q88615528 | Application of Integrated Drug Screening/Kinome Analysis to Identify Inhibitors of Gemcitabine-Resistant Pancreatic Cancer Cell Growth |
| Q36375641 | BIRC6 mediates imatinib resistance independently of Mcl-1. |
| Q97885933 | Bromodomain Inhibitors as Therapeutics for Herpesvirus-Related Disease: All BETs Are Off? |
| Q59360930 | Drug Repurposing for Viral Infectious Diseases: How Far Are We? |
| Q92153843 | Inhibition of MELK Protooncogene as an Innovative Treatment for Intrahepatic Cholangiocarcinoma |
| Q54960633 | Kinase inhibitors in clinical practice: An expanding world. |
| Q39278578 | Measuring Kinase Activity-A Global Challenge |
| Q55100648 | Methods and approaches to disease mechanisms using systems kinomics. |
| Q64892583 | Src Family Kinase Inhibitors Block Translation of Alphavirus Subgenomic mRNAs. |
| Q47552240 | The 5' Untranslated Region of the Major Immediate Early mRNA is Necessary for Efficient Human Cytomegalovirus Replication |
| Q46405641 | The Host-Pathogen Ecosystem Viewed Through the Prism of Proteomics |
Search more.